|

Anti-Thymoglobulin Clinical Trials

1 actively recruiting trial

Also known as: ATG

Pipeline

Phase 2: 1

Top Sponsors

  • Nantes University Hospital1

Indications

  • Graft-versus-host-disease1
  • Hematologic Malignancy1
  • Cancer1

Other1 trial

Study Testing Two Conditioning Regimen With a Single Prophylaxis of GVHD by Cyclophosphamide and Methotrexate Post-transplant in Patients Eligible for Matched-donor Allograft Transplantation
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.